Publications by authors named "Brigitte Robertson"

Claim this Profile
I
Improved Executive Function in Adults Diagnosed With Attention-Deficit/ Hyperactivity Disorder as Measured by the Brown Attention-Deficit Disorder Scale Following Treatment With SHP465 Mixed Amphetamine Salts Extended-Release: Post Hoc Analyses From 2 Randomized, Placebo-Controlled Studies.
Thomas E Brown, Jie Chen, Brigitte Robertson

J Atten Disord· January 2022

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
Functional impairment outcomes in clinical trials of different ADHD medications: post hoc responder analyses and baseline subgroup analyses.
David R Coghill, Tamara Werner-Kiechle, Sepehr Farahbakhshian, Caleb Bliss, Brigitte Robertson

Eur Child Adolesc Psychiatry· May 2021

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Phase 3, Randomized Double-Blind Study of the Efficacy and Safety of Low-Dose SHP465 Mixed Amphetamine Salts Extended-Release in Children with Attention-Deficit/Hyperactivity Disorder.
Greg Mattingly, Valerie Arnold, Brian Yan, Ming Yu, Brigitte Robertson

J Child Adolesc Psychopharmacol· November 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
Responder and Remission Analyses from Two Studies of SHP465 Mixed Amphetamine Salts Extended-Release Among Adults with Attention-Deficit/Hyperactivity Disorder.
Lenard A Adler, Brigitte Robertson, Jie Chen, Elias Sarkis

J Child Adolesc Psychopharmacol· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy of Guanfacine Extended Release in Children and Adolescents with Attention-Deficit/Hyperactivity Disorder and Comorbid Oppositional Defiant Disorder.
Jeffrey H Newcorn, Michael Huss, Daniel F Connor, Amaia Hervás, Tamara Werner-Kiechle, Brigitte Robertson

J Dev Behav Pediatr· September 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Relationships Between Executive Function Improvement and ADHD Symptom Improvement With Lisdexamfetamine Dimesylate in Adults With ADHD and Executive Function Deficits: A Post Hoc Analysis.
Thomas E Brown, Jie Chen, Brigitte Robertson

Prim Care Companion CNS Disord· May 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Lisdexamfetamine Dimesylate for Preschool Children with Attention-Deficit/Hyperactivity Disorder.
Ann C Childress, Robert L Findling, James Wu, Scott H Kollins, Yi Wang, Brigitte Robertson

J Child Adolesc Psychopharmacol· April 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Assessment of Amphetamine Withdrawal Symptoms of Lisdexamfetamine Dimesylate Treatment for Adults With Binge-Eating Disorder.
Brigitte Robertson, James Wu, Reginald V Fant, Sidney H Schnoll, Susan L McElroy

Prim Care Companion CNS Disord· March 2020

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Post-Hoc Analyses of the Effects of Baseline Sleep Quality on SHP465 Mixed Amphetamine Salts Extended-Release Treatment Response in Adults with Attention-Deficit/Hyperactivity Disorder.
Craig B H Surman, Brigitte Robertson, Jie Chen, Samuele Cortese

CNS Drugs· July 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effects of Food on the Bioavailability of Amphetamine in Healthy Adults After Administration of SHP465 Mixed Amphetamine Salts Extended-Release Capsules.
Yi Wang, Ming Yu, Brian Yan, Patrick Martin, Brigitte Robertson

Drugs R D· June 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A randomized, double-blind, 3-way crossover, analog classroom study of SHP465 mixed amphetamine salts extended-release in adolescents with ADHD.
Sharon Wigal, Frank Lopez, Glen Frick, Brian Yan, Brigitte Robertson

Postgrad Med· April 2019

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
L
Long-term safety and efficacy of guanfacine extended release in children and adolescents with ADHD.
Michael Huss, Bryan Dirks, Joan Gu, Brigitte Robertson, Jeffrey H Newcorn

Eur Child Adolesc Psychiatry· October 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An open-label positron emission tomography study to evaluate serotonin transporter occupancy following escalating dosing regimens of (R)-(-)-O-desmethylvenlafaxine and racemic O-desmethylvenlafaxine.
W Gordon Frankle, Brigitte Robertson, Gary Maier, Jennifer Paris, Deanna Asmonga

Synapse· March 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Children and Adolescents: Results of a Randomized, Double-Blind Placebo-Controlled Study.
Matthew Brams, Ann C Childress, Michael Greenbaum, Ming Yu, Brian Yan, Brigitte Robertson

J Child Adolesc Psychopharmacol· February 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Cognitive Function of Children and Adolescents with Attention-Deficit/Hyperactivity Disorder in a 2-Year Open-Label Study of Lisdexamfetamine Dimesylate.
David R Coghill, Tobias Banaschewski, Caleb Bliss, Brigitte Robertson, Alessandro Zuddas

CNS Drugs· January 2018

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of SHP465 Mixed Amphetamine Salts in the Treatment of Attention-Deficit/Hyperactivity Disorder in Adults: Results of a Randomized, Double-Blind, Placebo-Controlled, Forced-Dose Clinical Study.
Richard H Weisler, Michael Greenbaum, Valerie Arnold, Ming Yu, Brian Yan, Brigitte Robertson

CNS Drugs· August 2017

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Extended-release guanfacine hydrochloride in 6-17-year olds with ADHD: a randomised-withdrawal maintenance of efficacy study.
Jeffrey H Newcorn, Valerie Harpin, Michael Huss, Andrew Lyne, Vanja Sikirica, Brigitte Robertson

J Child Psychol Psychiatry· June 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
G
Guanfacine extended release for children and adolescents with attention-deficit/hyperactivity disorder: efficacy following prior methylphenidate treatment.
Michael Huss, Vanja Sikirica, Amaia Hervas, Jeffrey H Newcorn, Valerie Harpin, Brigitte Robertson

Neuropsychiatr Dis Treat· May 2016

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
A Randomized, Placebo-Controlled Trial of Guanfacine Extended Release in Adolescents With Attention-Deficit/Hyperactivity Disorder.
Timothy E Wilens, Brigitte Robertson, Vanja Sikirica, Linda Harper, Joel L Young

J Am Acad Child Adolesc Psychiatry· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Does Guanfacine Extended Release Impact Functional Impairment in Children with Attention-Deficit/Hyperactivity Disorder? Results from a Randomized Controlled Trial.
Mark A Stein, Vanja Sikirica, Margaret D Weiss, Brigitte Robertson, Andrew Lyne

CNS Drugs· November 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of extended-release guanfacine hydrochloride in children and adolescents with attention-deficit/hyperactivity disorder: a randomized, controlled, phase III trial.
Amaia Hervas, Michael Huss, Mats Johnson, Fiona McNicholas, Judy van Stralen, Brigitte Robertson

Eur Neuropsychopharmacol· December 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of atypical antipsychotic use among adolescents with attention-deficit/hyperactivity disorder.
Vanja Sikirica, Steven R Pliszka, Keith A Betts, Paul Hodgkins, Thomas M Samuelson, Brigitte Robertson

Am J Manag Care· September 2014

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Comparative treatment patterns, resource utilization, and costs in stimulant-treated children with ADHD who require subsequent pharmacotherapy with atypical antipsychotics versus non-antipsychotics.
Vanja Sikirica, Steven R Pliszka, Keith A Betts, Paul Hodgkins, Tom Samuelson, Brigitte Robertson

J Manag Care Pharm· May 2013

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
SEP-225289 serotonin and dopamine transporter occupancy: a PET study.
Christine DeLorenzo, Sarah Lichenstein, Karen Schaefer, Judith Dunn, Randall Marshall, Brigitte Robertson

J Nucl Med· July 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis